Skip to main content

Closed

ZNTL: Zentalis Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-65.4%

Financially safe

Stretched

Debt / equity0.21×

Interest coverage0.0×

Current ratio6.19×

Zentalis Pharmaceuticals, Inc.

ZNTLNASDAQ·USD·Closed

Zentalis Pharmaceuticals, Inc.

ZNTLNASDAQ·USD·Closed

$4.74

−3.66%

$4.74

−$0.18 (3.66%)

52W Range

61thpctl

Volume

0.81×avg

Mkt Cap

337.42MUSD

P/E

-2.7TTM

Div Yield

–ann

52W Range

61thpctl

Volume

0.81×avg

Market Cap

337.42MUSD

P/E Ratio

-2.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings